Literature DB >> 19738176

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration.

John M Ravits1, Albert R La Spada.   

Abstract

Heterogeneity of motor phenotypes is a clinically well-recognized fundamental aspect of amyotrophic lateral sclerosis (ALS) and is determined by variability of 3 independent primary attributes: body region of onset; relative mix of upper motor neuron (UMN) and lower motor neuron (LMN) deficits; and rate of progression. Motor phenotypes are determined by the anatomy of the underlying neuropathology and the common defining elements underlying their heterogeneity are that motor neuron degeneration is fundamentally a focal process and that it spreads contiguously through the 3-dimensional anatomy of the UMN and LMN levels, thus causing seemingly complex and varied clinical manifestations. This suggests motor neuron degeneration in ALS is in actuality a very orderly and actively propagating process and that fundamental molecular mechanisms may be uniform and their chief properties deduced. This also suggests opportunities for translational research to seek pathobiology directly in the less affected regions of the nervous system.

Entities:  

Mesh:

Year:  2009        PMID: 19738176      PMCID: PMC2739608          DOI: 10.1212/WNL.0b013e3181b6bbbd

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  48 in total

1.  Amyotrophic lateral sclerosis: a critique of a hypothesis.

Authors:  G Karpati; J Kimura
Journal:  Muscle Nerve       Date:  1992-02       Impact factor: 3.217

2.  Whole brain-based computerized neuroimaging in ALS and other motor neuron disorders.

Authors:  Julian Grosskreutz; Thomas Peschel; Alexander Unrath; Reinhard Dengler; Albert C Ludolph; Jan Kassubek
Journal:  Amyotroph Lateral Scler       Date:  2008-08

3.  The natural history of motoneuron loss in amyotrophic lateral sclerosis.

Authors:  T L Munsat; P L Andres; L Finison; T Conlon; L Thibodeau
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

4.  Motor neuron disease presenting with respiratory failure.

Authors:  M de Carvalho; T Matias; F Coelho; T Evangelista; A Pinto; M L Luís
Journal:  J Neurol Sci       Date:  1996-08       Impact factor: 3.181

5.  The natural history of amyotrophic lateral sclerosis and the use of natural history controls in therapeutic trials.

Authors:  J Pradas; L Finison; P L Andres; B Thornell; D Hollander; T L Munsat
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

6.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

Authors:  S S Gubbay; E Kahana; N Zilber; G Cooper; S Pintov; Y Leibowitz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 7.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

Review 8.  Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons.

Authors:  S M Chou; F H Norris
Journal:  Muscle Nerve       Date:  1993-08       Impact factor: 3.217

9.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

10.  Amyotrophic lateral sclerosis with marked neurological asymmetry: clinicopathological study.

Authors:  Y Mochizuki; T Mizutani; T Takasu
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more
  183 in total

Review 1.  Fungal Neurotoxins and Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Peter W French; Russell Ludowyke; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2018-12-05       Impact factor: 3.911

2.  Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.

Authors:  Leslie I Grad; Will C Guest; Anat Yanai; Edward Pokrishevsky; Megan A O'Neill; Ebrima Gibbs; Valentyna Semenchenko; Masoud Yousefi; David S Wishart; Steven S Plotkin; Neil R Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

Review 3.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

4.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 5.  Intercellular (mis)communication in neurodegenerative disease.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

6.  Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis.

Authors:  Pablo Díaz-Amarilla; Silvia Olivera-Bravo; Emiliano Trias; Andrea Cragnolini; Laura Martínez-Palma; Patricia Cassina; Joseph Beckman; Luis Barbeito
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-18       Impact factor: 11.205

Review 7.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

Review 8.  Amyotrophic lateral sclerosis--a model of corticofugal axonal spread.

Authors:  Heiko Braak; Johannes Brettschneider; Albert C Ludolph; Virginia M Lee; John Q Trojanowski; Kelly Del Tredici
Journal:  Nat Rev Neurol       Date:  2013-11-12       Impact factor: 42.937

9.  Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms.

Authors:  Leslie I Grad; Justin J Yerbury; Bradley J Turner; William C Guest; Edward Pokrishevsky; Megan A O'Neill; Anat Yanai; Judith M Silverman; Rafaa Zeineddine; Lisa Corcoran; Janet R Kumita; Leila M Luheshi; Masoud Yousefi; Bradley M Coleman; Andrew F Hill; Steven S Plotkin; Ian R Mackenzie; Neil R Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

10.  A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study.

Authors:  Atsushi Hashizume; Masahisa Katsuno; Keisuke Suzuki; Haruhiko Banno; Noriaki Suga; Tomoo Mano; Amane Araki; Yasuhiro Hijikata; Christopher Grunseich; Angela Kokkinis; Akihiro Hirakawa; Hirohisa Watanabe; Masahiko Yamamoto; Kenneth H Fischbeck; Gen Sobue
Journal:  Neuromuscul Disord       Date:  2015-03-20       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.